Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK.

Genes Dev. 2007 Nov 1;21(21):2683-710. Review.

2.

Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.

Lefranc F, Rynkowski M, DeWitte O, Kiss R.

Adv Tech Stand Neurosurg. 2009;34:3-35. Review.

PMID:
19368079
3.

Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.

Hargrave D.

Br J Neurosurg. 2009 Aug;23(4):351-63. doi: 10.1080/02688690903158809. Review.

PMID:
19637006
4.

Biology and treatment of malignant glioma.

Prados MD, Levin V.

Semin Oncol. 2000 Jun;27(3 Suppl 6):1-10. Review.

PMID:
10866344
5.

Emerging role of new transgenic mouse models in glioma research.

Sonabend AM, Ulasov IV, Lesniak MS.

Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S7-13. doi: 10.1586/14737140.7.12s.S7. Review.

PMID:
18076321
6.

Therapeutic strategies for inhibiting invasion in glioblastoma.

Drappatz J, Norden AD, Wen PY.

Expert Rev Neurother. 2009 Apr;9(4):519-34. doi: 10.1586/ern.09.10.

PMID:
19344303
7.

Neural and cancer stem cells in tumor suppressor mouse models of malignant astrocytoma.

Llaguno SA, Chen J, Kwon CH, Parada LF.

Cold Spring Harb Symp Quant Biol. 2008;73:421-6. doi: 10.1101/sqb.2008.73.005. Epub 2008 Nov 6. Review.

PMID:
19022744
8.

Current concepts in the pathology and genetics of gliomas.

Sarkar C, Jain A, Suri V.

Indian J Cancer. 2009 Apr-Jun;46(2):108-19. Review.

9.

Pathology and molecular genetics of astrocytic gliomas.

Reifenberger G, Collins VP.

J Mol Med (Berl). 2004 Oct;82(10):656-70. Review.

PMID:
15316624
10.

Malignant gliomas in children.

Johnson JH Jr, Phillips PC.

Cancer Invest. 1996;14(6):609-21. Review.

PMID:
8951364
11.

Novel therapies for malignant gliomas.

Cavaliere R, Wen PY, Schiff D.

Neurol Clin. 2007 Nov;25(4):1141-71, x. Review.

PMID:
17964029
12.

Molecular pathways triggering glioma cell invasion.

Salhia B, Tran NL, Symons M, Winkles JA, Rutka JT, Berens ME.

Expert Rev Mol Diagn. 2006 Jul;6(4):613-26. Review.

PMID:
16824034
13.

Chemotherapy and novel therapeutic approaches in malignant glioma.

Desjardins A, Rich JN, Quinn JA, Vredenburgh J, Gururangan S, Sathornsumetee S, Reardon DA, Friedman AH, Bigner DD, Friedman HS.

Front Biosci. 2005 Sep 1;10:2645-68. Review.

PMID:
15970525
14.

Recent advances in the molecular genetics of primary gliomas.

Kitange GJ, Templeton KL, Jenkins RB.

Curr Opin Oncol. 2003 May;15(3):197-203. Review.

PMID:
12778011
15.

Molecularly targeted therapy for malignant glioma.

Sathornsumetee S, Reardon DA, Desjardins A, Quinn JA, Vredenburgh JJ, Rich JN.

Cancer. 2007 Jul 1;110(1):13-24. Review.

16.

Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.

Hoelzinger DB, Demuth T, Berens ME.

J Natl Cancer Inst. 2007 Nov 7;99(21):1583-93. Epub 2007 Oct 30. Review.

PMID:
17971532
17.

Multidisciplinary management of adult anaplastic astrocytomas.

Chang S, Theodosopoulos P, Sneed P.

Semin Radiat Oncol. 2001 Apr;11(2):163-9. Review.

PMID:
11285554
18.

Malignant glioma: neuropathology and neurobiology.

Preusser M, Haberler C, Hainfellner JA.

Wien Med Wochenschr. 2006 Jun;156(11-12):332-7. Review.

PMID:
16944363
19.

Microglia in brain tumors.

Graeber MB, Scheithauer BW, Kreutzberg GW.

Glia. 2002 Nov;40(2):252-9. Review.

PMID:
12379912
20.

[Biology of gliomas].

Ducray F.

Cancer Radiother. 2008 Nov;12(6-7):663-8. doi: 10.1016/j.canrad.2008.09.001. Epub 2008 Oct 1. Review. French.

PMID:
18838326

Supplemental Content

Support Center